Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-0646
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study ; day:25 ; month:9 ; year:2021 ; pages:1-10
Investigational new drugs ; (25.9.2021), 1-10

Urheber
Thein, Kyaw Z.
Karp, Daniel D.
Tsimberidou, Apostolia
Gong, Jing
Sulovic, Selma
Shah, Jatin
Milton, Denái R.
Hong, David S.
Janku, Filip
McQuinn, Lacey
Stephen, Bettzy A.
Colen, Rivka
Carter, Brett W.
Yap, Timothy A.
Piha-Paul, Sarina A.
Fu, Siqing
Meric-Bernstam, Funda
Naing, Aung
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s10637-021-01188-1
URN
urn:nbn:de:101:1-2022011720111615918104
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Thein, Kyaw Z.
  • Karp, Daniel D.
  • Tsimberidou, Apostolia
  • Gong, Jing
  • Sulovic, Selma
  • Shah, Jatin
  • Milton, Denái R.
  • Hong, David S.
  • Janku, Filip
  • McQuinn, Lacey
  • Stephen, Bettzy A.
  • Colen, Rivka
  • Carter, Brett W.
  • Yap, Timothy A.
  • Piha-Paul, Sarina A.
  • Fu, Siqing
  • Meric-Bernstam, Funda
  • Naing, Aung
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors

Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy

Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report

Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab -Paclitaxel and Maintenance Monotherapy with nab -Paclitaxel: Two Case Reports

Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab -Paclitaxel and Maintenance Monotherapy with nab -Paclitaxel: Two Case Reports

Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien

Hochschulschrift

Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis

Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis

Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors

Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken

Fallstudiensammlung

Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken

Verbundene Objekte